PRMT1 expression predicts response to neoadjuvant chemotherapy for locally advanced uterine cervical cancer

The standard care for patients with locally advanced cervical cancer is concurrent chemoradiotherapy. Successful neoadjuvant chemotherapy (NAC) can reduce tumor size and enable patients to be eligible for a hysterectomy, which can improve their prognosis. Selecting the right candidate for NAC is imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimomura, Masahiro, Fukuda, Takeshi, Awazu, Yuichiro, Nanno, Shigenori, Inoue, Yuta, Matsubara, Hiroaki, Yamauchi, Makoto, Yasui, Tomoyo, Sumi, Toshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798043/
https://www.ncbi.nlm.nih.gov/pubmed/33552268
http://dx.doi.org/10.3892/ol.2020.12411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798043/
https://www.ncbi.nlm.nih.gov/pubmed/33552268
http://dx.doi.org/10.3892/ol.2020.12411

Ejemplares similares